Form 4: Elanco Animal Health Executive James Meer Reports Share Transaction
SEC Form 4 Filing
James Meer, Chief Accounting Officer of Elanco Animal Health, reports the disposal of 1,160 shares to cover tax liabilities upon vesting of restricted stock units.
Summary
- On July 3, 2024, James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc. (ELAN), disposed of 1,160 shares of common stock to cover tax obligations.
- The shares were tendered to the company at a price of $14.13 per share.
- Following the transaction, Meer directly owns 49,187 shares of Elanco Animal Health Inc.
- A power of attorney was executed on May 14, 2024, granting authority to Shiv O'Neill, Todd S. Young, Megan Y. Brady, Amy C. Seidel, and Amra Hoso to act on Meer's behalf regarding SEC filings.
Sentiment
Score: 7
Explanation: The document is a standard SEC filing related to stock transactions, indicating normal business operations. The sentiment is neutral to slightly positive as it reflects executive compensation and compliance.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Elanco Animal Health.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders as it is a routine executive stock transaction.
Key Dates
| Date | Description |
|---|---|
| 2024-05-14 | Date of Power of Attorney execution. |
| 2024-07-03 | Date of share disposal transaction. |
| 2024-07-08 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.